D'Aquila T, Hung YH, Carreiro A, Buhman KK
It suppresses the production of GnRH, LH and FSH and therefore suppresses the menstrual cycle
While orforglipron, another GLP-1 receptor agonist, has shown promising results in the ACHIEVE-1 clinical trial, ongoing research will further clarify how these options compare in terms of efficacy and safety
With Ozempics effectiveness in lowering blood sugar and decreasing body fat, some women are also beginning to wonder if this powerful drug could prove to be a tool in treating PCOS
This resource offers valuable insights and tips to keep you and your loved ones safe
Second, PWS patients have relatively lower visceral adipose tissue (VAT) and higher subcutaneous adipose tissue (SAT) compared to BMI-matched controls, though with some disputes [1]